Joel Becker
Chief Executive Officer at Neuropace Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Neuropace Inc., 3 years.
Neuropace Inc.
Director · CHIEF EXECUTIVE OFFICER
Chief executive roles
Neuropace Inc.
· Chief Executive Officer
Since July 2023
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 3, 2026 | Neuropace Inc. | Shares withheld for tax | −1,310 | $14.75 | $19,323 |
| Aug 27, 2026 | Neuropace Inc. | Shares withheld for tax | −1,126 | $14.13 | $15,910 |
| Jun 3, 2026 | Neuropace Inc. | Shares withheld for tax | −1,255 | $15.88 | $19,929 |
| May 27, 2026 | Neuropace Inc. | Shares withheld for tax | −1,126 | $17.06 | $19,210 |
| May 15, 2026 | Neuropace Inc. | Grant or award | +45,880 | — | — |
| Mar 3, 2026 | Neuropace Inc. | Shares withheld for tax | −5,023 | $13.83 | $69,468 |
| Feb 27, 2026 | Neuropace Inc. | Shares withheld for tax | −1,126 | $14.58 | $16,417 |
| Nov 27, 2025 | Neuropace Inc. | Shares withheld for tax | −1,126 | $16.50 | $18,579 |
| Aug 27, 2025 | Neuropace Inc. | Shares withheld for tax | −1,126 | $8.88 | $9,999 |
| May 27, 2025 | Neuropace Inc. | Shares withheld for tax | −1,126 | $12.66 | $14,255 |
| Mar 10, 2025 | Neuropace Inc. | Grant or award | +58,500 | — | — |
| Feb 27, 2025 | Neuropace Inc. | Shares withheld for tax | −4,506 | $12.56 | $56,595 |
| Feb 27, 2024 | Neuropace Inc. | Grant or award | +52,470 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.